← All Stoke Therapeutics, INC filings

Stoke Therapeutics, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
STOK
Stoke Therapeutics, INC
SCHEDULE: Stoke Therapeutics: Major Shareholder Group Drops Below 5% Stake
A group of reporting persons, including Blue Horizon Enterprise Ltd, has reduced its beneficial ownership in Stoke Therapeutics, Inc. to below the 5% threshold following a significant share sale.
NASDAQ
STOK
Stoke Therapeutics, INC
SCHEDULE 13D/A: Major Shareholder Group Reduces Stake in Stoke Therapeutics Following Share Sale
A group of reporting entities, including Ezbon International Ltd, has reduced its beneficial ownership in Stoke Therapeutics, Inc. to 6% after Ezbon sold 650,000 shares at $11.00 per share.
NASDAQ
STOK
Stoke Therapeutics, INC
SCHEDULE 13D/A: Major Shareholder Ezbon International Sells 3 Million Shares of Stoke Therapeutics
Ezbon International Ltd., a reporting person, has significantly reduced its stake in Stoke Therapeutics, Inc. by selling 3 million shares in an open market transaction.